- Exchange: Xetra
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Snapshot for Merck KGaA (MRK)
| Open: | 123.280 | Day's Range: | 121.950 - 125.000 | Volume: | 100,379 |
|---|---|---|---|---|---|
| Previous Close: | 123.300 | 52wk Range: | 75.470 - 127.500 | 1-Yr Rtn: | +59.24% |
Key Statistics for MRK
| Current P/E Ratio (ttm) | 41.1881 |
|---|---|
| Estimated P/E(12/2013) | 14.5522 |
| Relative P/E vs. DAX | 2.6732 |
| Earnings Per Share (EUR) (ttm) | 3.0300 |
| Est. EPS (EUR) (12/2013) | 8.5760 |
| Est. PEG Ratio | 2.1956 |
| Market Cap (M EUR) | 27,130.14 |
| Shares Outstanding (M) | 64.62 |
| 30 Day Average Volume | 245,862 |
| Price/Book (mrq) | 2.5864 |
| Price/Sale (ttm) | 2.4965 |
| Dividend Indicated Gross Yield | 1.36% |
| Cash Dividend (EUR) | 1.7000 |
| Last Dividend | 04/29/2013 |
| 5 Year Dividend Growth | 7.21% |
| Next Earnings Announcement | 08/06/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MRK
Company Profile & Key Executives for MRK
Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.
| Karl-Ludwig KleyChairman-Mgmt Board/CEO | Matthias ZachertCFO/Member-Mgmt Board |
| Kai BeckmannChief Administration Officer | Bernd ReckmannMember-Mgmt Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MRK News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page